ArticleACS medicinal chemistry letters2017

Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory Diseases.

Xiaohui He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.